CoChat

Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study

Open access
Sattar, Naveed, McMurray, John, Borén, Jan, Rawshani, Araz, Omerovic, Elmir, Berg, Niklas, Halminen, Janita, Skoglund, Kristoffer, Eliasson, Björn, Gerstein, Hertzel C., McGuire, Darren K., Bhatt, Deepak, Rawshani, Aidin · 2023 · Circulation
Cited by 116

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background: The goal of this work was to investigate trends (2001–2019) for cardiovascular events and cardiometabolic risk factor levels in individuals with type 2 diabetes (T2D) and matched control subjects. Methods: This study included 679 072 individuals with T2D from the Swedish National Diabetes Register and 2 643 800 matched control subjects. Incident outcomes comprised coronary artery disease, acute myocardial infarction, cerebrovascular disease, and heart failure (HF). Trends in time to first event for each outcome were analyzed with Cox regression and standardized incidence rates. In the group with T2D, Cox regression was also used to assess risk factor levels beyond target and outcomes, as well as the relative importance of each risk factor to each model. Results: Among individuals with T2D, incidence rates per 10 000 person-years in 2001 and 2019 were as follows: acute myocardial infarction, 73.9 (95% CI, 65.4–86.8) and 41.0 (95% CI, 39.5–42.6); coronary artery disease, 205.1 (95% CI, 186.8–227.5) and 80.2 (95% CI, 78.2–82.3); cerebrovascular disease, 83.9 (95% CI, 73.6–98.5) and 46.2 (95% CI, 44.9–47.6); and HF, 98.3 (95% CI, 89.4–112.0) and 75.9 (95% CI, 74.4–77.5). The incidence for HF plateaued around 2013, a trend that then persisted. In individuals with T2D, glycated hemoglobin, systolic blood pressure, estimated glomerular filtration rate, and lipids were independently associated with outcomes. Body mass index alone potentially explained >30% of HF risk in T2D. For those with T2D with no risk factor beyond target, there was no excess cardiovascular risk compared with control subjects except for HF, with increased hazard with T2D even when no risk factor was above target (hazard ratio, 1.50 [95% CI, 1.35–1.67]). Risk for coronary artery disease and cerebrovascular disease increased in a stepwise fashion for each risk factor not within target. Glycated hemoglobin was most prognostically important for incident atherosclerotic events, as was body mass index for incident of HF. Conclusions: Risk and rates for atherosclerotic complications and HF are generally decreasing among individuals with T2D, although HF incidence has notably plateaued in recent years. Modifiable risk factors within target levels were associated with lower risks for outcomes. This was particularly notable for systolic blood pressure and glycated hemoglobin for atherosclerotic outcomes and body mass index for heart failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.122.063374

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 15

  1. 10.1016/S0140-6736(98)07037-8 · DOI · Paper page
  2. 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  3. 10.1161/JAHA.117.006400 · DOI
  4. 10.1161/CIRCULATIONAHA.121.058072 · DOI
  5. 10.2337/dc22-0926 · DOI
  6. Harrell, F. Chapter 5. Rank of predictors. rms package in R; 2015.
  7. 10.1016/j.jacc.2018.08.2202 · DOI · Paper page
  8. 10.1161/ATVBAHA.119.311904 · DOI · Paper page
  9. 10.2337/dc20-0456 · DOI · Paper page
  10. 10.1161/CIRCRESAHA.118.311371 · DOI · Paper page
  11. 10.1161/CIRCULATIONAHA.116.025961 · DOI · Paper page
  12. Gaede, PH, Jepsen, PV, Larsen, JN, Jensen, GV, Parving, HH, Pedersen, OB. The Steno-2 Study: intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes [in Danish]. Ugeskr Laeger. 2003;165:2658–2661.
  13. 10.1093/eurheartj/ehz388 · DOI · Paper page
  14. 10.1056/NEJMx170008 · DOI · Paper page
  15. 10.1016/S2213-8587(22)00172-3 · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Sattar, N., McMurray, J., Borén, J., Rawshani, A., Omerovic, E., Berg, N., Halminen, J., Skoglund, K., Eliasson, B., Gerstein, H. C., McGuire, D. K., Bhatt, D., & Rawshani, A.
Venue
Circulation
Published
2023-06-20
Volume
147
Issue
25
Pages
1872-1886
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W4375862561
Cited by
116
References
15
FWCI
19.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study. https://app.cochat.ai/papers/10.1161/circulationaha.122.063374
The paper
Sattar, N., McMurray, J., Borén, J., Rawshani, A., Omerovic, E., Berg, N., Halminen, J., Skoglund, K., Eliasson, B., Gerstein, H. C., McGuire, D. K., Bhatt, D., & Rawshani, A. (2023). Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study. Circulation. https://doi.org/10.1161/circulationaha.122.063374

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.